This news helped Aarti Drugs to surge 11 per cent on August 17
This news helped Aarti Drugs to surge 11 per cent on August 17

This news helped Aarti Drugs to surge 11 per cent on August 17

Aarti Drugs Ltd is involved in the manufacturing and selling of Active Pharmaceutical Ingredients, Pharma Intermediates, Specialty Chemicals, and Formulations.

Vishwesh Sanas Article rating: 5.0

The shares of Aarti Drugs are rallying due to news regarding imposing anti-dumping duty on Chinese pharma companies to sell Ofloxacin and other intermediates in the Indian market.  

This small-cap stock which surged 9 per cent on Monday is recently purchased by ace investor Ashish Kacholia
This small-cap stock which surged 9 per cent on Monday is recently purchased by ace investor Ashish Kacholia

This small-cap stock which surged 9 per cent on Monday is recently purchased by ace investor Ashish Kacholia

Ashish Kacholia bought a 3.6 per cent stake in this small-cap stock, according to recent June quarterly filings.

Vishwesh Sanas Article rating: 3.9

Ashish Kacholia bought a 3.6 per cent stake in this small-cap stock, according to recent June quarterly filings. 

RSS
First678910121415

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR